Manjula Sidlagatta Ramakrishna

Manjula Sidlagatta Ramakrishna

Auto-generated profile, based on publicly available information

Manjula Sidlagatta Ramakrishna

SRM Med Coll Hosp & Res Ctr, SRM Inst Sci & Technol, Kattankulathur, Tamilnadu, India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
MRManjula Sidlagatta Ramakrishna
Manjula Sidlagatta Ramakrishna
LJLavanya Jeyamani
Lavanya Jeyamani
GAGomathi Chitra Abimannan
Gomathi Chitra Abimannan
KLKakithakara Vajravelu Leela
Kakithakara Vajravelu Leela
Skin and soft tissue infections (SSTIs) are the most common type of infection globally and also in India. Periodic evaluation of data on microbial profiling and antibiogram trend analysis is mandatory for creating a timely empirical treatment guideline and a proper antimicrobial cycling plan. In the current study, retrospective analysis of the data from 3,570 samples collected from suspected SSTI over one year was performed. Analysis was done on the clinical condition, causative agent/s identified and their antimicrobial susceptibility according to the standard guidelines. Seventy-three percent of samples yielded positive growth, with majority being unimicrobial infections. Gram-negative bacteria (GNB) were more commonly associated with infections from in-patients while Gram-positive cocci (GPC) were seen among out-patients. More than 70% of isolates among GNB were found susceptible to Carbapenems, piperacillin-tazobactam, amikacin and chloramphenicol. Among GPC, maximum sensitivity was seen to glycopeptides, linezolid followed by chloramphenicol, tetracycline, clindamycin and amikacin. Unusual resistance patterns like Penicillin resistant Ampicillin sensitive Enterococcus faecalis (PRASEF)strains, Multidrug resistance (MDR) and Extended drug resistance (XDR) were higher among Enterococci spp, MRSA, Acinetobacter spp and Klebsiella spp. Resistance to penicillin and cephalosporin drugs were high among GNB and GPC. Carbapenems, aminoglycosides, glycopeptides and broad-spectrum antibiotics are found sensitive and potential choices for empirical therapy. As prevalence of MDR and XDR strains were high and the trend analysis shows likelihood of few of the first and second line drugs becoming sensitive in future, we conclude that continued analysis of bacterial profiling and AMR pattern analysis among SSTI is essential.

14 November 2022 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
PSPavithra Selvan
Pavithra Selvan
KLKakithakara Vajravelu Leela
Kakithakara Vajravelu Leela
HMHemamalini Mohanraj
Hemamalini Mohanraj
MRManjula Sidlagatta Ramakrishna
Manjula Sidlagatta Ramakrishna

1 September 2021 in Journal of Clinical and Diagnostic Research
Verified
Journal Article
Open access
MRManjula Sidlagatta Ramakrishna
Manjula Sidlagatta Ramakrishna
GAGomathi Chitra Abimannan
Gomathi Chitra Abimannan
LJLavanya Jeyamani
Lavanya Jeyamani
ARAparna Ramalingam
Aparna Ramalingam
KAKarthik Anbalagan
Karthik Anbalagan
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.

1 September 2021 in Indian Journal of Medical Microbiology
Verified
Journal Article
Open access
SHS.R. Hariharan
S.R. Hariharan
SMS.R. Manjula
S.R. Manjula
KLK.V. Leela
K.V. Leela

1 July 2021 in National Journal of Laboratory Medicine
Verified
Journal Article
Closed access
GAGomathi Chitra Abimannan
Gomathi Chitra Abimannan
MRManjula Sidlagatta Ramakrishna
Manjula Sidlagatta Ramakrishna
LJLavanya Jeyamani
Lavanya Jeyamani
KAKarthik Anbalagan
Karthik Anbalagan
ARAparna Ramalingam
Aparna Ramalingam
Introduction: Urinary Tract Infection (UTI) is one of the most common infections, among patients who are hospitalised. Enterococci are one of the frequent isolates among UTI patients, gaining considerable clinical importance, due to their escalating drug resistance, affecting debilitated patients or patients with prolonged hospital stay. Among Multi-Drug Resistant (MDR) enterococci, glycopeptide-resistant enterococci are being increasingly reported. The intrinsic resistance of enterococci and their ability to acquire and disseminate antibiotic resistant genes to other organisms pose a challenge in the treatment of enterococcal infections with MDR. Aim: To investigate the prevalence of MDR, Extensively-Drug Resistant (XDR) and Pan-Drug Resistant (PDR) Enterococci spp. isolated from urine samples in a tertiary care centre. Materials and Methods: The present retrospective study was conducted to find the burden of drug resistant Enterococcus spp. in urine samples, analyse their antibiogram and patients’ socio-demographic information from January to December 2019. Records of microscopic observations to antibiogram of each isolate was noted down from the register for urine samples, and further analysed. The data was coded, verified, entered and analysed using Statistical Package for Social Sciences (SPSS) version 18.0. Results: The majority of patients 127 (20%) belonged to the age group of 21-30 years of age. Among 10,535 urine samples received, 635 culture isolates were identified as Enterococcus spp., of which 17.95%, 3.30% and 0.62% were identified as MDR, XDR and PDR enterococci, respectively. The antimicrobial susceptibility was found to be least for High Level Gentamicin (HLG) (66.14%), and penicillin (68.81%), followed by ampicillin (81.10%) and nitrofurantoin (86.40%). Twenty eight isolates (7.9%) were identified as Vancomycin Resistant Enterococci (VRE), 9 (2.5%) as linezolid resistant and 12 (3.4%) as linezolid intermediate enterococci. Conclusion: Identification and prevention of the alarming increase in MDR, XDR and PDR enterococci spp. is cardinal to prevent morbidity and mortality of affected patients. Analysis of antibiogram periodically, is important in selection of appropriate drugs to prevent the incoherent use of antibiotics.

14 October 2021 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
SHS.R. Hariharan
S.R. Hariharan
KLKakithakara Vajravelu Leela
Kakithakara Vajravelu Leela
SMS.R. Manjula
S.R. Manjula
ACA. Gomathi Chitra
A. Gomathi Chitra
AKA. Karthik
A. Karthik